All WMO-obligated studies require approval from the Radboudumc Board of Directors (RvB) before the study can start. This approval is issued when a number of conditions are met.

Team Policy, Quality and Support, on behalf of the Board of Directors, coordinates the procedure  for obtaining approval of (multicentre) research within the Radboudumc or where the Radboudumc is the sponsor. This is also called local feasibility. More information about the required steps can be found here.

In addition, the staff of the Radboudumc Technology Center (RTC) Clinical Studies offer support with the  various approval procedures for (clinical) research. For example, there is a great deal of experience in submitting a research file to obtain approval from reviewing bodies such as the Central Commission for Human Rights Research (CCMO), the Medical Ethics Review Committee (METC) and the Competent Authorities (BI). The RTC Clinical Studies will gladly support you in this process so that it runs as efficiently as possible and you can focus on your clinical research.


Further information? Contact the RTC Clinical Studies via email or tel: +31 (0) 24 366 83 33.